ESSA Pharma Inc.
EPIX · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$28,543 | -$26,582 | -$35,103 | -$36,805 |
| Dep. & Amort. | $91 | $118 | $122 | $109 |
| Deferred Tax | $0 | $0 | $0 | -$107 |
| Stock-Based Comp. | $6,539 | $5,007 | $8 | $9 |
| Change in WC | -$419 | $2,339 | -$780 | $1,947 |
| Other Non-Cash | -$384 | -$664 | -$831 | -$35 |
| Operating Cash Flow | -$22,716 | -$19,782 | -$28,704 | -$25,416 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$39,235 | -$365,204 | -$296,012 | -$57,026 |
| Inv. Sales/Matur. | $131,024 | $361,677 | $242,959 | $22,011 |
| Other Inv. Act. | $0 | $0 | $705 | -$35 |
| Investing Cash Flow | $91,789 | -$3,527 | -$52,348 | -$35,015 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$137 | -$134 | -$100 |
| Stock Issued | $926 | $69 | $387 | $150,000 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $69 | $387 | -$7,909 |
| Financing Cash Flow | $926 | -$68 | $253 | $141,991 |
| Forex Effect | $9 | $2 | $51 | -$56 |
| Net Chg. in Cash | $70,008 | -$23,375 | -$80,749 | $81,504 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $33,702 | $57,076 | $137,825 | $56,321 |
| End Cash | $103,710 | $33,702 | $57,076 | $137,825 |
| Free Cash Flow | -$22,716 | -$19,782 | -$28,704 | -$25,416 |